Agenus Inc. (AGEN)
USD 1.5
(-6.25%)
USD 1.5
(-6.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 274.13 Million USD | 373.46% |
| 2022 | -100.24 Million USD | 57.09% |
| 2021 | -233.64 Million USD | -429.28% |
| 2020 | -44.14 Million USD | -14.91% |
| 2019 | -38.41 Million USD | 3.23% |
| 2018 | -39.69 Million USD | -138.6% |
| 2017 | 102.83 Million USD | 89.56% |
| 2016 | 54.25 Million USD | 194.85% |
| 2015 | -57.19 Million USD | -67.25% |
| 2014 | -34.19 Million USD | -84.99% |
| 2013 | -18.48 Million USD | -227.93% |
| 2012 | 14.44 Million USD | -34.84% |
| 2011 | 22.17 Million USD | 53.85% |
| 2010 | 14.41 Million USD | -51.26% |
| 2009 | 29.57 Million USD | -32.04% |
| 2008 | 43.51 Million USD | -31.0% |
| 2007 | 63.06 Million USD | 23.03% |
| 2006 | 51.26 Million USD | 276.47% |
| 2005 | -29.04 Million USD | -379.51% |
| 2004 | -6.05 Million USD | 85.35% |
| 2003 | -41.34 Million USD | -26.9% |
| 2002 | -32.57 Million USD | 40.52% |
| 2001 | -54.77 Million USD | 39.92% |
| 2000 | -91.16 Million USD | -110.06% |
| 1999 | -43.4 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 317.86 Million USD | -104.36% |
| 2024 Q1 | 294.86 Million USD | 7.56% |
| 2023 Q2 | -55.85 Million USD | 27.52% |
| 2023 Q1 | -77.06 Million USD | 23.12% |
| 2023 FY | 274.13 Million USD | 373.46% |
| 2023 Q3 | -17.28 Million USD | 69.06% |
| 2023 Q4 | 274.13 Million USD | 1686.16% |
| 2022 FY | -100.24 Million USD | 57.09% |
| 2022 Q4 | -100.24 Million USD | 22.4% |
| 2022 Q3 | -129.18 Million USD | 12.83% |
| 2022 Q2 | -148.19 Million USD | 19.19% |
| 2022 Q1 | -183.39 Million USD | 21.51% |
| 2021 Q2 | -16.69 Million USD | 72.97% |
| 2021 Q1 | -61.74 Million USD | -39.87% |
| 2021 FY | -233.64 Million USD | -429.28% |
| 2021 Q3 | -201.93 Million USD | -1109.76% |
| 2021 Q4 | -233.64 Million USD | -15.7% |
| 2020 Q4 | -44.14 Million USD | 42.96% |
| 2020 Q1 | -62.82 Million USD | -63.55% |
| 2020 Q2 | -41.83 Million USD | 33.4% |
| 2020 FY | -44.14 Million USD | -14.91% |
| 2020 Q3 | -77.39 Million USD | -84.97% |
| 2019 Q2 | -99.5 Million USD | 27.6% |
| 2019 Q3 | -69.87 Million USD | 29.78% |
| 2019 FY | -38.41 Million USD | 3.23% |
| 2019 Q4 | -38.41 Million USD | 45.02% |
| 2019 Q1 | -137.44 Million USD | -246.25% |
| 2018 FY | -39.69 Million USD | -138.6% |
| 2018 Q2 | -30.11 Million USD | 23.65% |
| 2018 Q4 | -39.69 Million USD | -20.4% |
| 2018 Q3 | -32.96 Million USD | -9.49% |
| 2018 Q1 | -39.43 Million USD | -138.35% |
| 2017 Q2 | 41.91 Million USD | 105.05% |
| 2017 Q4 | 102.83 Million USD | 31.55% |
| 2017 FY | 102.83 Million USD | 89.56% |
| 2017 Q1 | 20.43 Million USD | -62.33% |
| 2017 Q3 | 78.17 Million USD | 86.52% |
| 2016 Q3 | 31.01 Million USD | 3134.66% |
| 2016 Q2 | -1.02 Million USD | 96.58% |
| 2016 Q1 | -29.92 Million USD | 47.68% |
| 2016 FY | 54.25 Million USD | 194.85% |
| 2016 Q4 | 54.25 Million USD | 74.95% |
| 2015 FY | -57.19 Million USD | -67.25% |
| 2015 Q1 | -67.8 Million USD | -98.27% |
| 2015 Q4 | -57.19 Million USD | 35.32% |
| 2015 Q3 | -88.43 Million USD | 31.03% |
| 2015 Q2 | -128.21 Million USD | -89.1% |
| 2014 Q2 | -55.38 Million USD | 13.64% |
| 2014 Q1 | -64.13 Million USD | -246.92% |
| 2014 FY | -34.19 Million USD | -84.99% |
| 2014 Q3 | -31.67 Million USD | 42.82% |
| 2014 Q4 | -34.19 Million USD | -7.98% |
| 2013 Q4 | -18.48 Million USD | 11.46% |
| 2013 FY | -18.48 Million USD | -227.93% |
| 2013 Q2 | -4.21 Million USD | -122.02% |
| 2013 Q1 | 19.13 Million USD | 32.43% |
| 2013 Q3 | -20.87 Million USD | -395.55% |
| 2012 Q1 | 8.71 Million USD | -60.68% |
| 2012 Q4 | 14.44 Million USD | 34.45% |
| 2012 FY | 14.44 Million USD | -34.84% |
| 2012 Q3 | 10.74 Million USD | 10.26% |
| 2012 Q2 | 9.74 Million USD | 11.79% |
| 2011 FY | 22.17 Million USD | 53.85% |
| 2011 Q4 | 22.17 Million USD | 35.34% |
| 2011 Q3 | 16.38 Million USD | -11.85% |
| 2011 Q2 | 18.58 Million USD | 1.92% |
| 2011 Q1 | 18.23 Million USD | 26.53% |
| 2010 Q3 | 35.23 Million USD | 15.18% |
| 2010 Q1 | 36 Million USD | 21.74% |
| 2010 Q2 | 30.59 Million USD | -15.03% |
| 2010 Q4 | 14.41 Million USD | -59.09% |
| 2010 FY | 14.41 Million USD | -51.26% |
| 2009 Q2 | 32.95 Million USD | -32.34% |
| 2009 Q3 | 19.1 Million USD | -42.04% |
| 2009 Q4 | 29.57 Million USD | 54.82% |
| 2009 FY | 29.57 Million USD | -32.04% |
| 2009 Q1 | 48.71 Million USD | 11.95% |
| 2008 FY | 43.51 Million USD | -31.0% |
| 2008 Q4 | 43.51 Million USD | -8.82% |
| 2008 Q3 | 47.72 Million USD | 20.65% |
| 2008 Q2 | 39.55 Million USD | -6.13% |
| 2008 Q1 | 42.13 Million USD | -33.19% |
| 2007 Q3 | 54.87 Million USD | 2.31% |
| 2007 FY | 63.06 Million USD | 23.03% |
| 2007 Q1 | 54.54 Million USD | 6.4% |
| 2007 Q4 | 63.06 Million USD | 14.92% |
| 2007 Q2 | 53.64 Million USD | -1.65% |
| 2006 FY | 51.26 Million USD | 276.47% |
| 2006 Q4 | 51.26 Million USD | 47.11% |
| 2006 Q3 | 34.84 Million USD | 9.61% |
| 2006 Q2 | 31.78 Million USD | 22.5% |
| 2006 Q1 | 25.95 Million USD | 189.34% |
| 2005 Q1 | 17.91 Million USD | 395.79% |
| 2005 Q4 | -29.04 Million USD | -246.35% |
| 2005 Q2 | 14.82 Million USD | -17.29% |
| 2005 FY | -29.04 Million USD | -379.51% |
| 2005 Q3 | 19.84 Million USD | 33.92% |
| 2004 Q2 | -35.64 Million USD | 38.71% |
| 2004 FY | -6.05 Million USD | 85.35% |
| 2004 Q3 | -26.15 Million USD | 26.63% |
| 2004 Q4 | -6.05 Million USD | 76.84% |
| 2004 Q1 | -58.15 Million USD | -40.67% |
| 2003 Q3 | -65.5 Million USD | -11.41% |
| 2003 Q1 | -70.55 Million USD | -116.56% |
| 2003 FY | -41.34 Million USD | -26.9% |
| 2003 Q4 | -41.34 Million USD | 36.88% |
| 2003 Q2 | -58.79 Million USD | 16.66% |
| 2002 Q4 | -32.57 Million USD | 23.17% |
| 2002 Q1 | -97.35 Million USD | -77.75% |
| 2002 Q2 | -53.8 Million USD | 44.73% |
| 2002 Q3 | -42.4 Million USD | 21.2% |
| 2002 FY | -32.57 Million USD | 40.52% |
| 2001 Q1 | -85.59 Million USD | 6.11% |
| 2001 Q2 | -77.69 Million USD | 9.24% |
| 2001 FY | -54.77 Million USD | 39.92% |
| 2001 Q4 | -54.77 Million USD | 15.9% |
| 2001 Q3 | -65.12 Million USD | 16.17% |
| 2000 Q2 | -102.56 Million USD | 3.8% |
| 2000 FY | -91.16 Million USD | -110.06% |
| 2000 Q3 | -99.18 Million USD | 3.3% |
| 2000 Q4 | -91.16 Million USD | 8.08% |
| 2000 Q1 | -106.61 Million USD | 0.0% |
| 1999 FY | -43.4 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 590.054% |
| Alkermes plc | -166.73 Million USD | 264.41% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 85.34% |
| Aptorum Group Limited | 1.35 Million USD | -20100.936% |
| Ardelyx, Inc. | 34.51 Million USD | -694.321% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -6305.047% |
| Bicycle Therapeutics plc | -481.46 Million USD | 156.938% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -658.057% |
| ChromaDex Corporation | -24.04 Million USD | 1239.953% |
| Chimerix, Inc. | -25.51 Million USD | 1174.327% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -3834.171% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 1257.816% |
| CRISPR Therapeutics AG | -150.84 Million USD | 281.734% |
| Precision BioSciences, Inc. | -85.41 Million USD | 420.965% |
| Dyadic International, Inc. | -6.37 Million USD | 4398.083% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 1820.555% |
| Fortress Biotech, Inc. | 7.66 Million USD | -3476.464% |
| Lantern Pharma Inc. | -21.7 Million USD | 1363.109% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 348.004% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 3308.83% |
| Incyte Corporation | -3.17 Billion USD | 108.634% |
| IO Biotech, Inc. | -140.69 Million USD | 294.839% |
| Jaguar Health, Inc. | 29.39 Million USD | -832.721% |
| Novavax, Inc. | -298.29 Million USD | 191.901% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -5036.519% |
| Opthea Limited | 28.15 Million USD | -873.583% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 1732.831% |
| ContextLogic Inc. | -232 Million USD | 218.162% |
| MiMedx Group, Inc. | -33.9 Million USD | 908.637% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -2588.926% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 11931.368% |
| NextCure, Inc. | -6.47 Million USD | 4332.453% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 642.833% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 4397.476% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -2153.802% |
| Vaxcyte, Inc. | -368.22 Million USD | 174.448% |
| PDS Biotechnology Corporation | -32.7 Million USD | 938.108% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -1486.619% |
| Pharming Group N.V. | 109.8 Million USD | -149.659% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 1675.857% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 256.444% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1580.227% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1580.227% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 3961.07% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 4778.089% |
| Acelyrin, Inc. | -216.9 Million USD | 226.386% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 4986.327% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 16001.16% |
| Summit Therapeutics Inc. | 34.67 Million USD | -690.61% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 4129.634% |
| Senti Biosciences, Inc. | 1.74 Million USD | -15654.943% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 248.497% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 453.948% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 4622.204% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -274670.72% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -43552.229% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 334.212% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 262.95% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -147.259% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 3708.952% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 312.321% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -3876.098% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 213.11% |
| Immix Biopharma, Inc. | -17.5 Million USD | 1665.615% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 186.559% |
| MEI Pharma, Inc. | -3.7 Million USD | 7499.082% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -2091.16% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -69.49% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -886.349% |
| Fortress Biotech, Inc. | 7.66 Million USD | -3476.464% |
| Precigen, Inc. | -481 Thousand USD | 57092.931% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -1846.85% |
| AlloVir, Inc. | -62.69 Million USD | 537.274% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 592.926% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -344.55% |
| ImmuCell Corporation | 10.99 Million USD | -2394.286% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 277.842% |
| Onconetix, Inc. | 5.33 Million USD | -5041.878% |
| PureTech Health plc | -167.19 Million USD | 263.96% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 999.987% |
| Elevation Oncology, Inc. | -19.11 Million USD | 1533.916% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 5684.355% |
| Seer, Inc. | -4.24 Million USD | 6565.472% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 1240.475% |
| Innoviva, Inc. | 255.56 Million USD | -7.267% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 590.72% |
| ESSA Pharma Inc. | -33.62 Million USD | 915.357% |
| GlycoMimetics, Inc. | -40.98 Million USD | 768.878% |
| GT Biopharma, Inc. | -1.02 Million USD | 26949.755% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 504.432% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -347.518% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 304.459% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 2078.464% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 1049.487% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 363994.125% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 988.264% |
| Aptose Biosciences Inc. | -8.19 Million USD | 3445.22% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 8861.087% |
| Soligenix, Inc. | -4.95 Million USD | 5636.315% |
| Century Therapeutics, Inc. | 847 Thousand USD | -32265.525% |
| Kura Oncology, Inc. | -20.11 Million USD | 1462.64% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 769.833% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 3364.301% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -14948.403% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 8674.789% |
| Autolus Therapeutics plc | -186.59 Million USD | 246.912% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 656.012% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 199.399% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -699.977% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -66.782% |
| GRI Bio, Inc. | -1.79 Million USD | 15380.713% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 3151.704% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 924.296% |
| IGM Biosciences, Inc. | -72.6 Million USD | 477.567% |
| INmune Bio, Inc. | -25.41 Million USD | 1178.808% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -81.606% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 641.14% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 1787.056% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 9602.358% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -621.126% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 765.621% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -759.765% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 27.468% |
| Verastem, Inc. | -37.27 Million USD | 835.383% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 3121.448% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 628.587% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 1911.272% |
| Histogen Inc. | -7.48 Million USD | 3761.493% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 1368.748% |
| Surrozen, Inc. | -32.66 Million USD | 939.26% |
| Organovo Holdings, Inc. | -1.5 Million USD | 18290.843% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 6621.632% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -1345.849% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -10379.205% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -6496.15% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 3370.864% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 731.039% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 1980.624% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 186.536% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 38065.82% |
| Apollomics, Inc. | -27.39 Million USD | 1100.679% |
| Amarin Corporation plc | -191.04 Million USD | 243.497% |
| Mesoblast Limited | 55.96 Million USD | -389.852% |
| Turnstone Biologics Corp. | -14.58 Million USD | 1979.704% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 1183.884% |
| Synaptogenix, Inc. | -28.66 Million USD | 1056.461% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 29388.034% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -462.538% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 31899.037% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 3872.818% |
| Exelixis, Inc. | -73.05 Million USD | 475.272% |
| Better Therapeutics, Inc. | -860 Thousand USD | 31976.279% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 1241.615% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 213.575% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -37143.399% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 3785.548% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -21760.925% |
| Gritstone bio, Inc. | 39.49 Million USD | -594.191% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 425.96% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 10514.948% |
| Avid Bioservices, Inc. | 169.72 Million USD | -61.515% |
| Insmed Incorporated | 721.62 Million USD | 62.011% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 3098.804% |
| MediWound Ltd. | -5.32 Million USD | 5250.996% |
| OmniAb, Inc. | 9.2 Million USD | -2878.768% |
| Alector, Inc. | -35.63 Million USD | 869.245% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -218.87% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 5662.825% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -1970.67% |
| Zai Lab Limited | -775 Million USD | 135.372% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 19.503% |
| Aura Biosciences, Inc. | -21.52 Million USD | 1373.57% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 432.367% |
| Immunic, Inc. | -45.34 Million USD | 704.623% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 241.881% |
| Veracyte, Inc. | -203.82 Million USD | 234.496% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 57.052% |
| FibroGen, Inc. | 56.76 Million USD | -382.914% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -2978.45% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 9796.783% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 13341.059% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 94.028% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 8305.208% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 265.178% |
| TG Therapeutics, Inc. | 17.86 Million USD | -1434.744% |
| Galecto, Inc. | -21.21 Million USD | 1392.119% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 1252.558% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 82.532% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 1220.203% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 2482.341% |
| XBiotech Inc. | -200.02 Million USD | 237.052% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 425.96% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -5954.24% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 877.404% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 455.016% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -4717.009% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 260.864% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 396.767% |
| Vaxxinity, Inc. | 10.13 Million USD | -2605.645% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 62.767% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 2645.946% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 515.635% |
| NexImmune, Inc. | -3.13 Million USD | 8848.157% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 8039.819% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 1914.095% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 1111.572% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 3154.082% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 220156.994% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 775.678% |
| Ainos, Inc. | 4.07 Million USD | -6622.434% |
| Pluri Inc. | 22.82 Million USD | -1100.824% |
| Prothena Corporation plc | -608.34 Million USD | 145.062% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 330.84% |
| Celularity Inc. | 65.19 Million USD | -320.518% |
| Rallybio Corporation | -24.1 Million USD | 1237.399% |
| Cue Biopharma, Inc. | -33.81 Million USD | 910.598% |
| MeiraGTx Holdings plc | -40.3 Million USD | 780.204% |
| Omeros Corporation | 331.17 Million USD | 17.223% |
| Humacyte, Inc. | -22.48 Million USD | 1319.141% |
| Immunocore Holdings plc | -358.59 Million USD | 176.447% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 1215.508% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 987.143% |
| Blueprint Medicines Corporation | 702.83 Million USD | 60.996% |
| CalciMedica, Inc. | -5.53 Million USD | 5057.251% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 245.647% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 2783.924% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 784.707% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 924.395% |
| Pulmatrix, Inc. | -10.41 Million USD | 2731.621% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 4686.515% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 818.725% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 346.078% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 557.32% |
| Cytokinetics, Incorporated | 642.37 Million USD | 57.324% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 4807.814% |
| Nutriband Inc. | -251.65 Thousand USD | 109032.396% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 903.47% |
| Vor Biopharma Inc. | 4.3 Million USD | -6275.256% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 104.542% |
| Evogene Ltd. | -19.63 Million USD | 1496.231% |
| ProKidney Corp. | -56.23 Million USD | 587.474% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 663.231% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 3067.743% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 79.901% |
| CorMedix Inc. | -43.05 Million USD | 736.748% |
| BioLineRx Ltd. | 7.33 Million USD | -3636.859% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 1098.129% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -494.049% |
| Atai Life Sciences N.V. | -28.55 Million USD | 1059.927% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -12190.179% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 1301.508% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -1445.734% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 465.154% |
| MediciNova, Inc. | -50.78 Million USD | 639.813% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 447.866% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1218753.034% |
| GeoVax Labs, Inc. | -6.45 Million USD | 4348.465% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 237.191% |
| Biomea Fusion, Inc. | -166.57 Million USD | 264.577% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 253.17% |
| Mereo BioPharma Group plc | -51.46 Million USD | 632.624% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 389.039% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 193.32% |
| Absci Corporation | -72.59 Million USD | 477.608% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -5903.855% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 216.934% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 390.981% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 386.465% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 801.6% |
| Allakos Inc. | -24.97 Million USD | 1197.642% |
| Imunon, Inc. | -4.21 Million USD | 6605.592% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 1959.558% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 302.464% |
| BioAtla, Inc. | -109.01 Million USD | 351.476% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -37143.399% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 29294.462% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -2190.958% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 1392.911% |
| XOMA Corporation | -29 Million USD | 1045.297% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 1755.411% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 3140.55% |
| aTyr Pharma, Inc. | -7.44 Million USD | 3780.172% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 319.949% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 231.692% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 435.216% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 395.523% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 32006.553% |
| Akari Therapeutics, Plc | -3.84 Million USD | 7229.675% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -16791.841% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 80.148% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 23172.799% |
| UroGen Pharma Ltd. | 4.39 Million USD | -6143.134% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -141.57% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -380845.499% |
| Orgenesis Inc. | 21.78 Million USD | -1158.428% |
| Entera Bio Ltd. | -10.62 Million USD | 2679.133% |
| GH Research PLC | -78.07 Million USD | 451.11% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 1329.971% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 1128.306% |
| Xencor, Inc. | 29.64 Million USD | -824.76% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 14016.861% |
| Replimune Group, Inc. | 1.41 Million USD | -19314.731% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 112034.277% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 316.851% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 23172.799% |
| Portage Biotech Inc. | -4.98 Million USD | 5603.634% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1218753.034% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 514.591% |
| OncoCyte Corporation | -6.56 Million USD | 4276.992% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -30447.362% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 6117.504% |
| Purple Biotech Ltd. | -14.13 Million USD | 2039.001% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 1253.965% |
| scPharmaceuticals Inc. | -6.54 Million USD | 4288.48% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 1742.303% |
| HilleVax, Inc. | -165.48 Million USD | 265.656% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 10901.261% |
| Tharimmune, Inc. | -10.93 Million USD | 2606.879% |
| Genprex, Inc. | -6.73 Million USD | 4168.731% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 174.33% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 409.898% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 19667.166% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 8364.711% |
| OKYO Pharma Limited | -826.84 Thousand USD | 33254.34% |
| Savara Inc. | 153 Thousand USD | -179073.856% |
| Curis, Inc. | -23.88 Million USD | 1247.637% |
| Daré Bioscience, Inc. | -5.15 Million USD | 5414.865% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 35426.258% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 4515.851% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -23033.84% |
| BeiGene, Ltd. | -2.25 Billion USD | 112.167% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -2121.794% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 145.073% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 247.714% |
| Erasca, Inc. | -37.21 Million USD | 836.608% |
| bluebird bio, Inc. | 108.57 Million USD | -152.495% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 21385.619% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 27.62% |
| DBV Technologies S.A. | -126.98 Million USD | 315.879% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 21385.619% |
| Moderna, Inc. | -2.9 Billion USD | 109.43% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 2748.145% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 2622.414% |
| Molecular Templates, Inc. | 707 Thousand USD | -38674.54% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 973.852% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 20.909% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 434.06% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 398.851% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 949.455% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 897.463% |
| MacroGenics, Inc. | -66.98 Million USD | 509.25% |
| RenovoRx, Inc. | -1.17 Million USD | 23470.503% |
| Adicet Bio, Inc. | -138.78 Million USD | 297.523% |
| Prime Medicine, Inc. | -27.94 Million USD | 1081.125% |
| Aditxt, Inc. | 18.12 Million USD | -1412.818% |
| Adagene Inc. | -87.62 Million USD | 412.843% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 6681.22% |
| Quantum-Si incorporated | -118.55 Million USD | 331.227% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -661.383% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 3767.77% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 665.124% |
| SciSparc Ltd. | -2.06 Million USD | 13375.351% |
| Vericel Corporation | 1.27 Million USD | -21367.189% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 2386.048% |
| Minerva Neurosciences, Inc. | 41 Million USD | -568.555% |
| Generation Bio Co. | 31.44 Million USD | -771.712% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 256.324% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 986.512% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -135.122% |
| Invivyd, Inc. | -198.47 Million USD | 238.12% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 403.685% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 11533.346% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 487.252% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 4116.645% |
| 2seventy bio, Inc. | 181.71 Million USD | -50.86% |
| ADMA Biologics, Inc. | 90.06 Million USD | -204.372% |
| Clene Inc. | 3.34 Million USD | -8107.665% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 3118.22% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 1374.399% |
| GeoVax Labs, Inc. | -6.45 Million USD | 4348.465% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 179.662% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 1154.382% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -54.299% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 6800.025% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -5380.528% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 5362.738% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 310.382% |
| Evaxion Biotech A/S | 5.28 Million USD | -5085.249% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 343.529% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 308.829% |
| Trevena, Inc. | 2.25 Million USD | -12040.655% |
| Surrozen, Inc. | -32.66 Million USD | 939.26% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 632.2% |
| Cingulate Inc. | 3.08 Million USD | -8792.773% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 9433.878% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -3714.331% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 3050.482% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 445.595% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 308.545% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 359.741% |
| Clearmind Medicine Inc. | -3.94 Million USD | 7053.113% |
| Kronos Bio, Inc. | -36.05 Million USD | 860.348% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -2813.551% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -18700.557% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 605.264% |
| Statera Biopharma, Inc. | 14.41 Million USD | -1801.556% |
| ImmunityBio, Inc. | 618.22 Million USD | 55.657% |
| Korro Bio, Inc. | -132.94 Million USD | 306.206% |
| Kineta, Inc. | -4.54 Million USD | 6136.908% |
| BioVie Inc. | -17.73 Million USD | 1645.965% |
| Codexis, Inc. | -43.27 Million USD | 733.533% |
| Celularity Inc. | 65.19 Million USD | -320.518% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 8750.552% |
| Celcuity Inc. | 6.78 Million USD | -3941.212% |
| Virax Biolabs Group Limited | -3.36 Million USD | 8246.822% |
| Cibus, Inc. | -8.07 Million USD | 3493.612% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 6582.289% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -5898.6% |
| IN8bio, Inc. | -16.38 Million USD | 1772.683% |
| Kodiak Sciences Inc. | -103.87 Million USD | 363.91% |
| Annexon, Inc. | -193.75 Million USD | 241.486% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -761388.889% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 1666.581% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 7903.473% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 73.998% |
| Eyenovia, Inc. | 1.25 Million USD | -21679.261% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -918.904% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 8553.161% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 924.544% |
| Arcellx, Inc. | -296.95 Million USD | 192.315% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 1505.393% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 565.624% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 1422.603% |
| Moolec Science SA | 117.61 Thousand USD | -232977.132% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 813.914% |
| Geron Corporation | 14.76 Million USD | -1757.164% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 822.971% |
| Royalty Pharma plc | 5.65 Billion USD | 95.155% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 293.844% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 4022.154% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 5211.751% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 294.794% |
| Humacyte, Inc. | -22.48 Million USD | 1319.141% |
| Structure Therapeutics Inc. | -124.33 Million USD | 320.475% |
| 89bio, Inc. | -289.05 Million USD | 194.839% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 1186.031% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 15474.986% |
| Genelux Corporation | -6.89 Million USD | 4073.561% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 982.63% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -227.918% |
| Notable Labs, Ltd. | -9.77 Million USD | 2904.173% |
| Liquidia Corporation | -80.17 Million USD | 441.918% |
| Mustang Bio, Inc. | -3.73 Million USD | 7437.687% |
| Immunovant, Inc. | -635.22 Million USD | 143.156% |
| Quantum-Si incorporated | -118.55 Million USD | 331.227% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 1660.783% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 6716.848% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -3315.174% |
| Acasti Pharma Inc. | -23 Million USD | 1291.637% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 8241.294% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 1787.056% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 299.024% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 8896.667% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 1333.069% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 1576.31% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 261.944% |
| PepGen Inc. | -60.67 Million USD | 551.848% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 1293.141% |
| United Therapeutics Corporation | -507.7 Million USD | 153.996% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 1533.316% |
| Solid Biosciences Inc. | -47.75 Million USD | 674.107% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 31899.037% |
| Immuneering Corporation | -54.94 Million USD | 598.947% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 6621.632% |
| Silo Pharma, Inc. | -3.52 Million USD | 7878.435% |
| Belite Bio, Inc | -87.27 Million USD | 414.12% |
| XOMA Corporation | -29 Million USD | 1045.297% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 487.762% |
| Bionomics Limited | 227 Million USD | -20.759% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 335.751% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 10922.582% |
| uniQure N.V. | -102.95 Million USD | 366.278% |
| Cassava Sciences, Inc. | -121.13 Million USD | 326.304% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 6681.22% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -569.424% |
| Forte Biosciences, Inc. | -11.96 Million USD | 2391.915% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 8959.673% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -258518.868% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 8553.161% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -2978.45% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 3796.548% |
| Altimmune, Inc. | -134.48 Million USD | 303.838% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -38.407% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 10922.582% |
| Compugen Ltd. | -12.9 Million USD | 2224.427% |
| Peak Bio, Inc. | 10.34 Million USD | -2551.178% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 96967.845% |
| Benitec Biopharma Inc. | -50.58 Million USD | 641.964% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 362.738% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -1295.449% |
| Zura Bio Limited | -99.8 Million USD | 374.669% |
| PolyPid Ltd. | 6.17 Million USD | -4343.047% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -269.854% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -1295.449% |
| Instil Bio, Inc. | 75.35 Million USD | -263.778% |
| argenx SE | -2.02 Billion USD | 113.512% |
| Immunome, Inc. | -97.02 Million USD | 382.53% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 1318.653% |
| Verona Pharma plc | -220.44 Million USD | 224.357% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 482.108% |
| Shattuck Labs, Inc. | -121.42 Million USD | 325.768% |
| CervoMed Inc. | -7.79 Million USD | 3617.791% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 247.783% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 6368.831% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 308.089% |
| Moolec Science SA | 117.61 Thousand USD | -232977.132% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 12081.589% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -1624.301% |
| AnaptysBio, Inc. | -18.15 Million USD | 1610.308% |
| Design Therapeutics, Inc. | -18.15 Million USD | 1610.391% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 489.503% |
| NeurAxis, Inc. | 145.7 Thousand USD | -188050.995% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -2340.67% |
| Lumos Pharma, Inc. | -28.49 Million USD | 1062.117% |
| Achilles Therapeutics plc | -126.92 Million USD | 315.984% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 482.108% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 41906.231% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 1419.622% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -18700.557% |
| Nutriband Inc. | -251.65 Thousand USD | 109032.396% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 2181.361% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 3784.624% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 19.418% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -1054.986% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 161.263% |
| Palisade Bio, Inc. | -12.06 Million USD | 2372.536% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 295.377% |
| Beam Therapeutics Inc. | -262.72 Million USD | 204.345% |
| Neurogene Inc. | -131.95 Million USD | 307.75% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -1156.582% |
| AEON Biopharma, Inc. | -4.88 Million USD | 5717.541% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 172.678% |
| Sesen Bio, Inc. | -112.55 Million USD | 343.562% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 374.52% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 11776.328% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 802.445% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 429.166% |
| Athira Pharma, Inc. | -88.99 Million USD | 408.021% |
| Vaccinex, Inc. | -1.28 Million USD | 21383.851% |
| HCW Biologics Inc. | 2.85 Million USD | -9496.328% |
| XOMA Corporation | -29 Million USD | 1045.297% |
| Nektar Therapeutics | 210.24 Million USD | -30.392% |
| Arvinas, Inc. | -313.8 Million USD | 187.36% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -16791.841% |
| Merus N.V. | -192.88 Million USD | 242.125% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -357.008% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 4051.225% |
| Rezolute, Inc. | -68.16 Million USD | 502.148% |
| Clene Inc. | 3.34 Million USD | -8107.665% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 2178.835% |
| BeyondSpring Inc. | -13.75 Million USD | 2092.992% |
| Synlogic, Inc. | -6.68 Million USD | 4200.763% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -24074.25% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 3342.295% |
| Peak Bio, Inc. | 10.34 Million USD | -2551.178% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 432.609% |
| Krystal Biotech, Inc. | -350.23 Million USD | 178.272% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -120.855% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 262.214% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 8783.038% |
| MannKind Corporation | 143.89 Million USD | -90.506% |
| Ikena Oncology, Inc. | -109.15 Million USD | 351.141% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 3720.869% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 928.205% |
| Gossamer Bio, Inc. | 180.35 Million USD | -51.998% |
| CohBar, Inc. | -5.93 Million USD | 4722.297% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 1021.527% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -5903.855% |
| Legend Biotech Corporation | -949.39 Million USD | 128.875% |
| Mural Oncology plc | -255.84 Million USD | 207.15% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -750.958% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 5919.504% |
| Disc Medicine, Inc. | -358.28 Million USD | 176.514% |
| Champions Oncology, Inc. | 4.81 Million USD | -5596.924% |
| REGENXBIO Inc. | 54.76 Million USD | -400.54% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 102044.538% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 281.518% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 3141.898% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 439.769% |
| Vaxart, Inc. | -8.24 Million USD | 3426.49% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 646.306% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 315.574% |
| Cellectis S.A. | -43.85 Million USD | 725.096% |
| Longeveron Inc. | -2.9 Million USD | 9526.96% |
| Repare Therapeutics Inc. | -107.85 Million USD | 354.164% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 71.691% |
| Inozyme Pharma, Inc. | 12 Million USD | -2183.705% |
| Revolution Medicines, Inc. | -608.2 Million USD | 145.073% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 22387.48% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 203.402% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 282.67% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 1852.004% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 37145.405% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 102.866% |
| Denali Therapeutics Inc. | -74.86 Million USD | 466.174% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 2386.048% |
| Veru Inc. | 4.77 Million USD | -5635.1% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 2537.631% |
| Cingulate Inc. | 3.08 Million USD | -8792.773% |
| Passage Bio, Inc. | 4.58 Million USD | -5878.975% |
| Context Therapeutics Inc. | -14.44 Million USD | 1997.158% |
| Exicure, Inc. | 5.84 Million USD | -4586.887% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 218.995% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 792.787% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -1647.091% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 566.051% |
| Nuvalent, Inc. | -335.38 Million USD | 181.737% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -15706.35% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 468.057% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 3183.645% |
| OmniAb, Inc. | 9.2 Million USD | -2878.768% |
| Anew Medical, Inc. | 1.43 Million USD | -19037.361% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -1573.423% |
| Lipocine Inc. | -4.75 Million USD | 5865.71% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 349.605% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -1699.856% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 641.14% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -1001.302% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 4178.798% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 516.449% |
| Ocugen, Inc. | -32.52 Million USD | 942.951% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 420.346% |
| Q32 Bio Inc. | -37.94 Million USD | 822.399% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 43752.229% |
| Alumis Inc. Common Stock | -13.52 Million USD | 2126.284% |
| Equillium, Inc. | -22.39 Million USD | 1324.259% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 1172.184% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 940.218% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 110676.609% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -104.515% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -8472.108% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -83365.828% |
| Dominari Holdings Inc. | 195 Thousand USD | -140482.564% |
| Edesa Biotech, Inc. | -5.26 Million USD | 5304.873% |
| vTv Therapeutics Inc. | -8.91 Million USD | 3174.308% |
| Bio-Techne Corporation | 267.74 Million USD | -2.386% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 1791.258% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 332.134% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 3362.359% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 2266.912% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 211.838% |
| Nkarta, Inc. | 57.29 Million USD | -378.431% |
| BioCardia, Inc. | 212 Thousand USD | -129209.434% |
| Iterum Therapeutics plc | 13.43 Million USD | -1940.006% |